Nature Communications (Nov 2023)

HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis

  • Michael F. Emmons,
  • Richard L. Bennett,
  • Alberto Riva,
  • Kanchan Gupta,
  • Larissa Anastasio Da Costa Carvalho,
  • Chao Zhang,
  • Robert Macaulay,
  • Daphne Dupéré-Richér,
  • Bin Fang,
  • Edward Seto,
  • John M. Koomen,
  • Jiannong Li,
  • Y. Ann Chen,
  • Peter A. Forsyth,
  • Jonathan D. Licht,
  • Keiran S. M. Smalley

DOI
https://doi.org/10.1038/s41467-023-43519-1
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Melanomas can adopt multiple transcriptional states. Little is known about the epigenetic drivers of these cell states, limiting our ability to regulate melanoma heterogeneity. Here, we identify stress-induced HDAC8 activity as driving melanoma brain metastasis development. Exposure of melanocytes and melanoma cells to multiple stresses increases HDAC8 activation leading to a neural crest-stem cell transcriptional state and an amoeboid, invasive phenotype that increases seeding to the brain. Using ATAC-Seq and ChIP-Seq we show that increased HDAC8 activity alters chromatin structure by increasing H3K27ac and enhancing accessibility at c-Jun binding sites. Functionally, HDAC8 deacetylates the histone acetyltransferase EP300, causing its enzymatic inactivation. This, in turn, increases binding of EP300 to Jun-transcriptional sites and decreases binding to MITF-transcriptional sites. Inhibition of EP300 increases melanoma cell invasion, resistance to stress and increases melanoma brain metastasis development. HDAC8 is identified as a mediator of transcriptional co-factor inactivation and chromatin accessibility that drives brain metastasis.